Guijun Ning

580 total citations
11 papers, 226 citations indexed

About

Guijun Ning is a scholar working on Epidemiology, Microbiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Guijun Ning has authored 11 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Microbiology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Guijun Ning's work include Bacterial Infections and Vaccines (5 papers), Respiratory viral infections research (4 papers) and Pneumonia and Respiratory Infections (4 papers). Guijun Ning is often cited by papers focused on Bacterial Infections and Vaccines (5 papers), Respiratory viral infections research (4 papers) and Pneumonia and Respiratory Infections (4 papers). Guijun Ning collaborates with scholars based in China, United States and Japan. Guijun Ning's co-authors include Zundong Yin, Yixing Li, Huaqing Wang, Xuxia Wang, Weizhong Yang, Dan Wu, Huiming Luo, Guomin Zhang, Lixin Hao and Lisa A. Lee and has published in prestigious journals such as Vaccine, American Journal of Tropical Medicine and Hygiene and Human Vaccines & Immunotherapeutics.

In The Last Decade

Guijun Ning

10 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guijun Ning China 6 124 80 64 45 43 11 226
Jerzy Brzostek Poland 9 189 1.5× 61 0.8× 32 0.5× 82 1.8× 25 0.6× 14 239
Olivia Almendares United States 7 332 2.7× 60 0.8× 110 1.7× 28 0.6× 34 0.8× 17 436
Inga Ivaškevičienė Lithuania 8 110 0.9× 113 1.4× 55 0.9× 18 0.4× 31 0.7× 17 231
Sarah Radke New Zealand 10 152 1.2× 43 0.5× 26 0.4× 56 1.2× 42 1.0× 14 308
Abass Abdul-Karim Ghana 9 111 0.9× 43 0.5× 103 1.6× 58 1.3× 33 0.8× 18 253
Emin Sami Arısoy Türkiye 10 94 0.8× 128 1.6× 51 0.8× 19 0.4× 16 0.4× 26 311
Dave Jackson Canada 6 147 1.2× 127 1.6× 116 1.8× 103 2.3× 47 1.1× 7 299
Ouzama Henry United States 9 201 1.6× 50 0.6× 78 1.2× 10 0.2× 59 1.4× 21 245
Kheya Ghosh Uttam India 2 78 0.6× 79 1.0× 50 0.8× 16 0.4× 6 0.1× 5 184
Harish Madhava United Kingdom 7 207 1.7× 37 0.5× 42 0.7× 60 1.3× 14 0.3× 20 262

Countries citing papers authored by Guijun Ning

Since Specialization
Citations

This map shows the geographic impact of Guijun Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guijun Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guijun Ning more than expected).

Fields of papers citing papers by Guijun Ning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guijun Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guijun Ning. The network helps show where Guijun Ning may publish in the future.

Co-authorship network of co-authors of Guijun Ning

This figure shows the co-authorship network connecting the top 25 collaborators of Guijun Ning. A scholar is included among the top collaborators of Guijun Ning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guijun Ning. Guijun Ning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
He, Yulei, Fengli Zhao, Xiao Yang, et al.. (2025). Phase I open-label study of the respiratory syncytial virus monoclonal antibody clesrovimab: Safety and tolerability in healthy Chinese participants. Human Vaccines & Immunotherapeutics. 21(1). 2516948–2516948.
2.
Wu, Dan, Yixing Li, Zhujun Shao, et al.. (2019). [Acute meningitis and encephalitis syndrome surveillance disease burden in four China prefectures].. PubMed. 53(2). 164–168. 3 indexed citations
3.
Yu, Wenzhou, Lisa A. Lee, Yanmin Liu, et al.. (2018). Vaccine-preventable disease control in the People’s Republic of China: 1949–2016. Vaccine. 36(52). 8131–8137. 49 indexed citations
4.
Ning, Guijun, Zundong Yin, Yixing Li, Huaqing Wang, & Weizhong Yang. (2017). Cost-effectiveness of the Haemophilus influenzae type b vaccine for infants in mainland China. Human Vaccines & Immunotherapeutics. 14(1). 36–44. 10 indexed citations
5.
Ning, Guijun, Xuxia Wang, Dan Wu, et al.. (2017). The etiology of community-acquired pneumonia among children under 5 years of age in mainland China, 2001–2015: A systematic review. Human Vaccines & Immunotherapeutics. 13(11). 2742–2750. 72 indexed citations
6.
Yin, Zundong, Xuxia Wang, Li Li, et al.. (2015). Neurological Sequelae of Hospitalized Japanese Encephalitis Cases in Gansu Province, China. American Journal of Tropical Medicine and Hygiene. 92(6). 1125–1129. 38 indexed citations
7.
Li, Junhong, Yixing Li, Zhujun Shao, et al.. (2014). Prevalence of meningococcal meningitis in China from 2005 to 2010. Vaccine. 33(8). 1092–1097. 21 indexed citations
8.
Yin, Zundong, Garrett R. Beeler Asay, Yixing Li, et al.. (2012). An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China. Vaccine. 30(37). 5569–5577. 28 indexed citations
9.
Guo, Yuhong, Jinglin Wang, Guichang Li, et al.. (2010). Preliminary investigation of vector mosquitoes in Nyingtri, Tibet.. Zhongguo meijie shengwuxue ji kongzhi zazhi. 21(4). 300–302. 2 indexed citations
10.
Li, Junhong, et al.. (2010). Surveillance of meningococcal disease in China, 2009.. Jibing jiance. 25(10). 770–780. 2 indexed citations
11.
Ning, Guijun, Junhong Li, & Zundong Yin. (2009). [Analysis of prevalence season and trend of meningococcal disease by circular distribution in China].. PubMed. 15(6). 536–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026